Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02572167
Brief Title: A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma

First Submitted : October 7, 2015
First Submitted that Met QC Criteria : October 7, 2015
First Posted : October 8, 2015 (Estimate)

Results First Submitted : February 13, 2019
Results First Submitted that Met QC Criteria : February 13, 2019
Results First Posted : March 7, 2019

Last Update Submitted that Met QC Criteria : April 18, 2019
Last Update Posted : May 1, 2019